Patrick Perkins MD in Liberty, Missouri

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: Saint Louis University School Of Medicine
Graduation Year: 1994
The Primary Medical Specialty for Patrick Perkins MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 30
PAC (PECOS ID)#: 2163464256
NPI #: 1437159308
NPI Created On: 07/21/2005
NPI Last Updated Listed as: 01/18/2020
Primary Taxonomy Code: 207RP1001X
License Number:
04-32394
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medica Insurance Company
• Celtic Insurance Company
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. X-ray of chest, 2 views
3. Vaccine for influenza for injection into muscle
4. Measurement and graphic recording of total and timed exhaled air capacity
5. Measurement and graphic recording of total and timed exhaled air capacity
6. Test for exercise-induced lung stress
7. Determination of lung volumes using plethysmography
8. Measurement of lung diffusing capacity
9. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
10. New patient office or other outpatient visit, typically 30 minutes
11. New patient office or other outpatient visit, typically 45 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Initial hospital inpatient care, typically 50 minutes per day
15. Initial hospital inpatient care, typically 70 minutes per day
16. Subsequent hospital inpatient care, typically 25 minutes per day
17. Subsequent hospital inpatient care, typically 35 minutes per day
18. Critical care delivery critically ill or injured patient, first 30-74 minutes
19. Administration of influenza virus vaccine
20. Injection, mepolizumab, 1 mg